Specialty Pharmacy

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.

The approval of riluzole oral suspension fills a therapeutic need for patients with amyotrophic lateral sclerosis who develop swallowing impairment.

Hub services act to simplify the complexity and perform as an intermediary between involved parties.

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection.

Through their Medicaid and Ryan White HIV/AIDS Programs, states play an integral role in ensuring access to care for people living with HIV.

Study provides insight into how cannabidiol acts in the brain to reduce psychotic symptoms.

New report assesses the quality of rheumatic disease care across all 50 states and calls for improvements that address access to affordable care.

FDA has granted priority review designation for Merck’s request for a supplemental biologics license application for pembrolizumab to treat Merkel cell carcinoma, a rare skin cancer.

Patients with multiple sclerosis who smoked cigarettes had higher rates of respiratory complications and increased sedentary lifestyle.

Top news of the day from across the health care landscape.

Some older women undergoing chemotherapy for breast cancer may be more susceptible to declining physical function and inability to recover function.

Combined ipilimumab and nivolumab treatment produced durable responses in patients with melanoma brain metastases.

Supplementing a commonly used treatment approach with an additional inhibitor could help overcome resistance in glioblastoma.

Gordon Vanscoy, PharmD, MBA, explains the challenges patients face when being treated with orphan drugs, and how pharmacists can help overcome these challenges.

Top news of the day from across the health care landscape.

Final approval for Sympazan, the oral soluble film formulation of clobazam, is pending the expiration of the orphan drug exclusivity period for ONFI.

The sugar-removing enzyme may lessen the demand for universal blood donors.

Survivors of breast cancer and their families face long-term cumulative financial implications from treatment and associated costs.

Even as market disruptors such as Amazon raise concerns, pharmacies prove that the services they provide yield valuable patient experiences.

A look at last week's top stories in the world of pharmacy.

Combining pembrolizumab (Keytruda) and an investigational drug could benefit patients with advanced melanoma who have not responded to immunotherapy treatment.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

The approvals of Delstrigo and Pifeltro are based on findings from 2 phase 3 clinical trials.

Medicare Part D plans will be given flexibility to tailor on-formulary drug coverage based on specific indications.